Impact of a pulmonary embolism response team initiative on hospital mortality of patients with bilateral pulmonary embolism

Ramos-López, Noemi; Ferrera, Carlos; Luque, Tania; Enríquez-Vázquez, Daniel; Mahia, Patricia; Galván-Herráez, Laura; Pedrajas, José María; Salinas, Pablo; Noriega, Francisco J.; Fraile, Pablo Zulet; Islas, Fabián; Real, Carlos; Mejía‐Rentería, Hernán; Jiménez‐Quevedo, Pilar; Gonzalo, Nieves; Núñez‐Gil, Iván J.; Nombela‐Franco, Luis; Tirado, Gabriela; Macaya, Fernando; Escaned, Javier; Hernández, Ana María Mañas; Bustamante, José Manuel Díaz de; Serrano, Mónica Pérez; García, Esther Bernardo; Pozzi, María Aranzazu Ortega; Higueras, Javier; Agustin, José Alberto de; Viana-Tejedor, Ana; Fernández-Ortíz, Antonio

doi:10.1016/j.medcli.2022.12.017

Cited by 7 publications

(2 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This approach has had a favorable impact on coordination between specialties and treatment decision-making. Notably, PERT-initiated care versus standard of care has been associated with reduced 12-month mortality in patients with high- and intermediate high-risk PE [ 21 ]. In PERT team discussions, consideration should be given to the need for mechanical circulatory support.…”

Section: Treatmentmentioning

confidence: 99%

See 1 more Smart Citation

Mechanical Circulatory Support Devices in Patients with High-Risk Pulmonary Embolism

Ellauzi,

Erdem,

Salam

et al. 2024

JCM

View full text Add to dashboard Cite

Pulmonary embolism (PE) is a common acute cardiovascular condition. Within this review, we discuss the incidence, pathophysiology, and treatment options for patients with high-risk and massive pulmonary embolisms. In particular, we focus on the role of mechanical circulatory support devices and their possible therapeutic benefits in patients who are unresponsive to standard therapeutic options. Moreover, attention is given to device selection criteria, weaning protocols, and complication mitigation strategies. Finally, we underscore the necessity for more comprehensive studies to corroborate the benefits and safety of MCS devices in PE management.

show abstract

Section: Treatmentmentioning

confidence: 99%

“…Thrombolytic therapy should be considered, and given first over anticoagulation. If thrombolytic medication is administered, cardiopulmonary resuscitation should be maintained until resuscitative efforts are deemed to be futile [ 5 , 21 , 29 ].…”

Section: Treatmentmentioning

confidence: 99%